ACCESSION: MSBNK-SMB_Measured-HSA015P0125005
RECORD_TITLE: Characterized; 2,3,4,6,7,8-hexahydropyrrolo[1,2-a]pyrimidine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 18
COMMENT: RAW_SPEC {'EL24_pos_2751': {'bp': 979973.0, 'sum': 2692546.0}, 'EL01_pos_2721': {'bp': 524626.0, 'sum': 1888899.0}, 'EL10_pos_2716': {'bp': 490070.0, 'sum': 1571000.0}, 'EL07_pos_2715': {'bp': 489448.0, 'sum': 1641487.0}, 'EL11_pos_2703': {'bp': 477169.0, 'sum': 1595536.0}, 'EL02_pos_2721': {'bp': 441472.0, 'sum': 1765258.0}, 'EL06_pos_2721': {'bp': 431086.0, 'sum': 1547015.0}, 'EL04_pos_2739': {'bp': 414067.0, 'sum': 1569234.0}, 'EL09_pos_2709': {'bp': 370402.0, 'sum': 1382883.0}, 'EL20_pos_2711': {'bp': 370353.0, 'sum': 1325179.0}, 'EL03_pos_2909': {'bp': 362292.0, 'sum': 1730566.0}, 'EL18_pos_2723': {'bp': 332080.0, 'sum': 1297205.0}, 'EL08_pos_2722': {'bp': 315288.0, 'sum': 1355249.0}, 'EL14_pos_2716': {'bp': 293965.0, 'sum': 1264864.0}, 'EL17_pos_2714': {'bp': 293103.0, 'sum': 1193945.0}, 'EL13_pos_2721': {'bp': 287797.0, 'sum': 1231637.0}, 'EL21_pos_2715': {'bp': 210013.0, 'sum': 987705.0}, 'EL15_pos_2710': {'bp': 201918.0, 'sum': 987479.0}}
COMMENT: RETENTION_TIME_STDEV 0.059
COMMENT: PRECURSOR_M/Z_RAW 125.107652
COMMENT: PRECURSOR_M/Z_STDEV 0.000036
COMMENT: PRECURSOR_IN_MS1 mz 125.107353; int 45.651; delta(ppm) 0.712434
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.226; C7H12N2; [M+H]+; delta(ppm) 0.225624
COMMENT: PROPOSED_MF MS-FINDER 3.166; C7H12N2; [M+H]+; delta(ppm) 0.217178
COMMENT: PROPOSED_MF SIRIUS5_Sirius 16.850; C7H12N2; [M+H]+; delta(ppm) 0.217178
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H12N2; [M+H]+; delta(ppm) 0.217178
COMMENT: PROPOSED_MF SIRIUS6_Sirius 26.481; C7H12N2; [M+H]+; delta(ppm) 0.217178
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H12N2; [M+H]+; delta(ppm) 0.217178
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.744; UVQPDGXQIPNYNU-UHFFFAOYSA-N; [M+H]+; CCN1CN(C=C1)C=C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.425; SLLDUURXGMDOCY-UHFFFAOYSA-N; [M+H]+; CCCCC1=NC=CN1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.914; UVQPDGXQIPNYNU-UHFFFAOYSA-N; [M+H]+; 1-ethenyl-3-ethyl-2H-imidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.845; SLLDUURXGMDOCY-UHFFFAOYSA-N; [M+H]+; 2-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; UVQPDGXQIPNYNU-UHFFFAOYSA-N; [M+H]+; 1-ethenyl-3-ethyl-2H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.933; SLLDUURXGMDOCY-UHFFFAOYSA-N; [M+H]+; 2-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.806; SGUVLZREKBPKCE-UHFFFAOYSA-N; [M+H]+; 2,3,4,6,7,8-hexahydropyrrolo[1,2-a]pyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.607; MCMFEZDRQOJKMN-UHFFFAOYSA-N; [M+H]+; 1-butylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.009; SLLDUURXGMDOCY-UHFFFAOYSA-N; [M+H]+; 2-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.869; HUMMCZRNZCKXHL-UHFFFAOYSA-N; [M+H]+; 1-aminocyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.518; PDVYZQGNSCSKPG-UHFFFAOYSA-N; [M+H]+; 3-pyrrolidin-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.458; YIDCITOHTLPMMZ-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.434; KMUHAJOXPNPERW-UHFFFAOYSA-N; [M+H]+; (1,5-dimethylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.411; UVQPDGXQIPNYNU-UHFFFAOYSA-N; [M+H]+; 1-ethenyl-3-ethyl-2H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.407; CLVBVRODHJFTGF-UHFFFAOYSA-N; [M+H]+; 2-piperidin-1-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.333; GUFHZYGWUDAKJR-UHFFFAOYSA-N; [M+H]+; (5-ethyl-1H-pyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.276; UFLLSVUGUWBXJA-UHFFFAOYSA-N; [M+H]+; 3,5-diethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.257; LOCUKVKZMLTDJC-UHFFFAOYSA-N; [M+H]+; 1-(1-methylpyrrol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.256; VIXYONLJAGTTOD-UHFFFAOYSA-N; [M+H]+; 4-methylpiperidine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.248; KLKXWOZRCZWLNA-UHFFFAOYSA-N; [M+H]+; 5-methylpiperidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.248; BVGQGPWKBMTPNM-UHFFFAOYSA-N; [M+H]+; 5-methyl-2-propyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.247; AMQKPABOPFXDQM-UHFFFAOYSA-N; [M+H]+; 1-tert-butylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.245; XMTHAWZPEGHZPK-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrrol-3-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.243; GFJCGXFXOXSUJX-UHFFFAOYSA-N; [M+H]+; 5-butyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.241; MGSZBMLUKBKFIH-UHFFFAOYSA-N; [M+H]+; 4-ethyl-3,5-dimethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.239; ZVTFIBQPABQXLK-UHFFFAOYSA-N; [M+H]+; 2-piperidin-4-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.238; IGSGRZGYPSFKAS-UHFFFAOYSA-N; [M+H]+; 4-butan-2-yl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.232; KJENYXWFEZWBBS-UHFFFAOYSA-N; [M+H]+; (2,5-dimethyl-1H-pyrrol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.222; ITGMTNOYOPHQAE-UHFFFAOYSA-N; [M+H]+; 4-aminocyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.220; RVGOKHBYNZPVGI-UHFFFAOYSA-N; [M+H]+; 2-aminocyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.220; MXDKDPXBTLQXNF-RNFRBKRXSA-N; [M+H]+; 2-[(1S,3R)-3-aminocyclopentyl]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.215; ITFDYXKCBZEBDG-UHFFFAOYSA-N; [M+H]+; 2-(1-methylpyrrol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.204; GWCSATTUAOHJDK-UHFFFAOYSA-N; [M+H]+; 1-prop-2-ynylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.204; CTUNHIMNHSKDBN-UHFFFAOYSA-N; [M+H]+; 2-tert-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.195; IYTBULKZSACADZ-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.195; WOPVVVYENHYREL-UHFFFAOYSA-N; [M+H]+; 2-amino-2-cyclopentylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.179; HZJOVDAZLMBPPZ-UHFFFAOYSA-N; [M+H]+; 2-piperidin-3-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.175; BJIDGKXFJLYGNA-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-1-(1H-pyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.161; IEGLIUHTOPMAFW-UHFFFAOYSA-N; [M+H]+; 1-(2-isocyanoethyl)pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.158; JYOKDJPITDWCEZ-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; ULKZTFQDSPKNMV-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.142; IJRFANCSEQXUNT-UHFFFAOYSA-N; [M+H]+; 2-(methylamino)cyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.139; SWEZGJVIOFBJBX-UHFFFAOYSA-N; [M+H]+; 5-methyl-4-propan-2-yl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.136; NKYDATLMFPYEJM-UHFFFAOYSA-N; [M+H]+; 4-(2-methylpropyl)-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.124; OZLQTEIBZXQTLQ-UHFFFAOYSA-N; [M+H]+; 2-cyclopropyl-2-(methylamino)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; KNIPASVZFLFVSD-UHFFFAOYSA-N; [M+H]+; 1-(methylamino)cyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.113; QOLDCHQHOOFRGQ-UHFFFAOYSA-N; [M+H]+; 1-methyl-3-propan-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.095; WLUJHMKCLOIRSK-UHFFFAOYSA-N; [M+H]+; 1,2,4,5-tetramethylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; QUSOBKIKODRYSH-UHFFFAOYSA-N; [M+H]+; 1-tert-butylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.060; GDRRCHJTUJBMQA-UHFFFAOYSA-N; [M+H]+; 2-methyl-1-propan-2-ylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.041; SFRZJVGGJFNWHZ-UHFFFAOYSA-N; [M+H]+; 4-tert-butyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.036; CNRYJJXBFLHSJP-UHFFFAOYSA-N; [M+H]+; 3-pyrrol-1-ylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.010; UGOZVQRJDQYTKT-UHFFFAOYSA-N; [M+H]+; N-methyl-2-pyrrol-1-ylethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -32.887; SGUVLZREKBPKCE; [M+H]+; 1,5-Diazabicyclo[4.3.0]-5-nonene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -100.078; IEGLIUHTOPMAFW; [M+H]+; 1-(2-isocyanoethyl)pyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -101.525; KVMUMGRJMXZCMW; [M+H]+; 2-Ethyl-5,6-dihydro-3-methylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -105.515; PDVYZQGNSCSKPG; [M+H]+; 1-Pyrrolidinepropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -115.035; CLVBVRODHJFTGF; [M+H]+; Piperidoacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -140.297; ZVTFIBQPABQXLK; [M+H]+; piperidinylacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -146.829; HQOXLKBFOCPYAE; [M+H]+; 5,7-dimethyl-2,3-dihydro-1H-1,4-diazepine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -149.531; GWCSATTUAOHJDK; [M+H]+; Ambcb4040562
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -150.693; HUMMCZRNZCKXHL; [M+H]+; Ambcb4036030
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -156.337; YVYGFQPWNRTJNS; [M+H]+; 2,3,5-Trimethyl-5,6-dihydropyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.919; WLUJHMKCLOIRSK; [M+H]+; 1,2,4,5-Tetramethylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.990; CNRYJJXBFLHSJP; [M+H]+; Ambcb4027319
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -216.160; GFJCGXFXOXSUJX; [M+H]+; 3-Butylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -226.249; MCMFEZDRQOJKMN; [M+H]+; N-Butylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.740; OKDQKPLMQBXTNH; [M+H]+; Pyridinamine,N,N-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -237.618; ITFDYXKCBZEBDG; [M+H]+; 1-Methyl-1H-pyrrole-2-ethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -243.690; SLLDUURXGMDOCY; [M+H]+; 2-Butylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.699; YIDCITOHTLPMMZ; [M+H]+; Bionet2_000181
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -266.910; XMTHAWZPEGHZPK; [M+H]+; 1-(1H-pyrrol-3-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -269.178; KMUHAJOXPNPERW; [M+H]+; (1,5-dimethylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -287.529; CTUNHIMNHSKDBN; [M+H]+; Ambcb4039818
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -288.785; RFXJLECGYGFJCI; [M+H]+; Ambcb4039941
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.758; SGUVLZREKBPKCE; [M+H]+; 1,5-Diazabicyclo[4.3.0]-5-nonene
COMMENT: CONFIDENCE Level 3: Tentative candidate, 1,5-Diazabicyclo[4.3.0]-5-nonene, SGUVLZREKBPKCE-UHFFFAOYSA-N; Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0001406;
CH$NAME: 2,3,4,6,7,8-hexahydropyrrolo[1,2-a]pyrimidine
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C7H12N2
CH$EXACT_MASS: 124.100048
CH$SMILES: C1CC2=NCCCN2C1
CH$IUPAC: InChI=1S/C7H12N2/c1-3-7-8-4-2-6-9(7)5-1/h1-6H2
CH$LINK: INCHIKEY SGUVLZREKBPKCE-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:76349
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 4.405
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 125.107352
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-056r-8900000000-5c834a44044163b4997b
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0389083 9.6690 53.039606 1.2444 3.50 0.3681 13 f{C4H5}/6.25ppm,p-C3H8N2
  55.0545050 15.8481 55.055213 1.2170 7.04 0.3478 18 f{C4H7}/5.06ppm,p-C3H6N2
  56.0497296 26.3220 56.050442 0.9099 6.41 0.7181 17 f{C3H6N1}/4.53ppm,p-C4H7N1
  56.9650034 10.7360 56.965719 0.8426 5.06 -0.1517 18 ?
  58.0653880 976.4417 58.066108 0.2756 28.04 0.2570 18 f{C3H8N1}/4.52ppm,p-C4H5N1
  67.0543992 13.3986 67.055141 0.8053 5.95 0.2571 15 f{C5H7}/2.57ppm,p-C2H6N2
  68.0496320 8.7132 68.050374 1.1021 3.68 0.0471 16 f{C4H6N1}/2.30ppm,p-C3H7N1
  70.0652584 117.7148 70.066002 0.2426 27.21 0.8101 18 f{C4H8N1}/1.89ppm,p-C3H5N1
  79.0543102 28.1894 79.055042 0.9234 11.71 0.4216 17 f{C6H7}/1.06ppm,p-C1H6N2
  80.0495294 29.0817 80.050259 0.9869 10.24 0.1930 18 f{C5H6N1}/0.67ppm,p-C2H7N1
  81.0699236 37.1644 81.070650 1.1102 16.79 0.2054 18 f{C6H9}/0.58ppm,p-C1H4N2
  82.0651813 83.9846 82.065904 0.3656 5.31 0.3375 18 f{C5H8N1}/0.68ppm,p-C2H5N1
  82.9419307 11.2959 82.942651 1.2901 4.78 0.0147 16 ?
  83.0604245 8.7877 83.061144 1.3364 3.72 0.1357 15 f{C4H7N2}/0.60ppm,p-C3H6
  84.0808567 55.7509 84.081572 0.6422 5.36 0.3313 18 f{C5H10N1}/0.96ppm,p-C2H3N1
  84.9597499 154.6711 84.960462 0.1766 57.63 -0.0568 18 ?
  96.0443742 32.9698 96.045019 1.0308 16.04 0.0319 17 ?
  97.0760479 115.3570 97.076685 0.4739 32.84 0.8844 18 f{C5H9N2}/0.24ppm,p-C2H4
  102.9703201 13.9047 102.970905 1.3402 5.88 0.0217 18 ?
  108.0807757 17.8356 108.081311 1.3046 9.08 0.9077 14 f{C7H10N1}/-0.00ppm,p-H3N1
  110.0838951 44.2932 110.084417 0.7721 33.12 0.6718 18 f{C6H10N2}/0.41ppm,p-C1H3
  118.9629666 9.4212 118.963416 1.1852 3.80 0.2882 16 ?
  123.0552528 36.7948 123.055662 0.9670 11.03 0.2853 16 ?
  124.0393586 58.1451 124.039758 0.7256 24.77 -0.0444 18 ?
  124.0756935 45.6963 124.076093 0.7415 13.85 0.5521 18 ?
  124.1120589 9.4521 124.112458 1.2328 3.07 0.0857 14 ?
  125.0709804 75.8489 125.071369 0.6157 34.76 0.4283 18 ?
  125.1073547 499.2076 125.107743 0.2878 153.54 1.0000 18 f{C7H13N2}/0.24ppm,p
  126.0549697 28.3844 126.055348 0.9440 10.15 0.6264 18 ?
  126.0913162 18.2559 126.091694 0.8565 7.49 0.2095 18 ?
  126.1109748 42.6535 126.111353 1.0388 13.92 0.9051 18 ?
  127.0389633 16.3426 127.039331 0.9210 7.47 0.3500 16 ?
  127.1230029 999.0000 127.123370 0.2753 17.77 0.2941 18 ?
PK$NUM_PEAK: 33
PK$PEAK: m/z int. rel.int.
  53.038908 9.67 9
  55.054505 15.85 15
  56.049730 26.32 26
  56.965003 10.74 10
  58.065388 976.44 976
  67.054399 13.40 13
  68.049632 8.71 8
  70.065258 117.71 117
  79.054310 28.19 28
  80.049529 29.08 29
  81.069924 37.16 37
  82.065181 83.98 83
  82.941931 11.30 11
  83.060425 8.79 8
  84.080857 55.75 55
  84.959750 154.67 154
  96.044374 32.97 32
  97.076048 115.36 115
  102.970320 13.90 13
  108.080776 17.84 17
  110.083895 44.29 44
  118.962967 9.42 9
  123.055253 36.79 36
  124.039359 58.15 58
  124.075693 45.70 45
  124.112059 9.45 9
  125.070980 75.85 75
  125.107355 499.21 499
  126.054970 28.38 28
  126.091316 18.26 18
  126.110975 42.65 42
  127.038963 16.34 16
  127.123003 999.00 999
//
